On November 29 2024 Pieris Pharmaceuticals was traded for 16.83 at the closing time. The top price for the day was 17.09 and the lowest listed price was 16.52 . There was no trading activity during the period 0.0. Lack of trading volume on November 29, 2024 did not cause price change. The trading delta at closing time against the current closing price is 1.54% .
Other Forecasting Options for Pieris Pharmaceuticals
For every potential investor in Pieris, whether a beginner or expert, Pieris Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Pieris Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Pieris. Basic forecasting techniques help filter out the noise by identifying Pieris Pharmaceuticals' price trends.
Pieris Pharmaceuticals Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Pieris Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Pieris Pharmaceuticals' current price.
Market strength indicators help investors to evaluate how Pieris Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pieris Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Pieris Pharmaceuticals stock market strength indicators, traders can identify Pieris Pharmaceuticals entry and exit signals to maximize returns.
The analysis of Pieris Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Pieris Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting pieris stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Thematic Opportunities
Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
When running Pieris Pharmaceuticals' price analysis, check to measure Pieris Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pieris Pharmaceuticals is operating at the current time. Most of Pieris Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pieris Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pieris Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pieris Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.